Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
Biochemistry
|
May 1, 1990
Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA
D J Fernandes, M K Danks, W T Beck
Cancer Research
|
June 1, 1979
Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts
W T Beck, T J Mueller, L R Tanzer
Cancer Research
|
January 15, 1988
Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line
A B Hill, W T Beck, J M Trent
Cancer Research
|
September 1, 1991
Characterization of multidrug resistance by fluorescent dyes
D Kessel, W T Beck, D Kukuruga, et al.
Biotechniques
|
December 24, 1998
Overexpression of human DNA topoisomerase II alpha by fusion to enhanced green fluorescent protein
Y Y Mo, K A Ameiss, W T Beck
Advances in Enzyme Regulation
|
January 1, 1990
Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance
H L Pearce, M A Winter, W T Beck
Biochemical and Biophysical Research Communications
|
September 26, 1972
The in vivo stimulation of rat liver ornithine decarboxylase activity by dibutyryl cyclic adenosine 3',5'-monophosphate, theophylline and dexamethasone
W T Beck, R A Bellantone, E S Canellakis
Cancer Research
|
September 1, 1986
Differentiation and the multiple drug resistance phenotype in human leukemic cells
W T Beck, M C Cirtain, R A Ashmun, et al.
Cancer Research
|
August 15, 1991
Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells
E Friche, M K Danks, C A Schmidt, et al.
Cancer Research
|
August 1, 1992
DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors
J S Wolverton, M K Danks, B Granzen, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
Biochemistry
|
May 1, 1990
Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA
D J Fernandes, M K Danks, W T Beck
Cancer Research
|
June 1, 1979
Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts
W T Beck, T J Mueller, L R Tanzer
Cancer Research
|
January 15, 1988
Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line
A B Hill, W T Beck, J M Trent
Cancer Research
|
September 1, 1991
Characterization of multidrug resistance by fluorescent dyes
D Kessel, W T Beck, D Kukuruga, et al.
Biotechniques
|
December 24, 1998
Overexpression of human DNA topoisomerase II alpha by fusion to enhanced green fluorescent protein
Y Y Mo, K A Ameiss, W T Beck
Advances in Enzyme Regulation
|
January 1, 1990
Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance
H L Pearce, M A Winter, W T Beck
Biochemical and Biophysical Research Communications
|
September 26, 1972
The in vivo stimulation of rat liver ornithine decarboxylase activity by dibutyryl cyclic adenosine 3',5'-monophosphate, theophylline and dexamethasone
W T Beck, R A Bellantone, E S Canellakis
Cancer Research
|
September 1, 1986
Differentiation and the multiple drug resistance phenotype in human leukemic cells
W T Beck, M C Cirtain, R A Ashmun, et al.
Cancer Research
|
August 15, 1991
Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells
E Friche, M K Danks, C A Schmidt, et al.
Cancer Research
|
August 1, 1992
DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors
J S Wolverton, M K Danks, B Granzen, et al.
Page
of 11